122 related articles for article (PubMed ID: 18310171)
21. Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10).
Dollfus C; Le Chenadec J; Faye A; Blanche S; Briand N; Rouzioux C; Warszawski J
Clin Infect Dis; 2010 Jul; 51(2):214-24. PubMed ID: 20536367
[TBL] [Abstract][Full Text] [Related]
22. Immunological markers after long-term treatment interruption in chronically HIV-1 infected patients with CD4 cell count above 400 x 10(6) cells/l.
Thiébaut R; Pellegrin I; Chêne G; Viallard JF; Fleury H; Moreau JF; Pellegrin JL; Blanco P
AIDS; 2005 Jan; 19(1):53-61. PubMed ID: 15627033
[TBL] [Abstract][Full Text] [Related]
23. Response to changes in antiretroviral therapy after genotyping in human immunodeficiency virus-infected children.
Cohen NJ; Oram R; Elsen C; Englund JA
Pediatr Infect Dis J; 2002 Jul; 21(7):647-53. PubMed ID: 12237597
[TBL] [Abstract][Full Text] [Related]
24. Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents.
Soh CH; Oleske JM; Brady MT; Spector SA; Borkowsky W; Burchett SK; Foca MD; Handelsman E; Jiménez E; Dankner WM; Hughes MD;
Lancet; 2003 Dec; 362(9401):2045-51. PubMed ID: 14697803
[TBL] [Abstract][Full Text] [Related]
25. [Structured therapeutic interruption in patients infected with HIV-1 experiencing a block in their antiretroviral treatment: preliminary results].
Rey D; Schmitt MP; Hess-Kempf G; Krantz V; Partisani M; Bernard-Henry C; Lang JM
Pathol Biol (Paris); 2001 Sep; 49(7):559-66. PubMed ID: 11642019
[TBL] [Abstract][Full Text] [Related]
26. Hospital-based directly observed therapy for HIV-infected children and adolescents to assess adherence to antiretroviral medications.
Glikman D; Walsh L; Valkenburg J; Mangat PD; Marcinak JF
Pediatrics; 2007 May; 119(5):e1142-8. PubMed ID: 17452493
[TBL] [Abstract][Full Text] [Related]
27. Neurocognitive functioning in pediatric human immunodeficiency virus infection: effects of combined therapy.
Shanbhag MC; Rutstein RM; Zaoutis T; Zhao H; Chao D; Radcliffe J
Arch Pediatr Adolesc Med; 2005 Jul; 159(7):651-6. PubMed ID: 15996999
[TBL] [Abstract][Full Text] [Related]
28. CD4+ cell-count-guided treatment interruptions in chronic HIV-infected patients with good response to highly active antiretroviral therapy.
Boschi A; Tinelli C; Ortolani P; Moscatelli G; Morigi G; Arlotti M
AIDS; 2004 Dec; 18(18):2381-9. PubMed ID: 15622314
[TBL] [Abstract][Full Text] [Related]
29. Retrospective analysis of suspending HAART in selected patients with controlled HIV replication.
Jacobs B; Neil N; Aboulafia DM
AIDS Patient Care STDS; 2005 Jul; 19(7):429-38. PubMed ID: 16053400
[TBL] [Abstract][Full Text] [Related]
30. Deformed Subcortical Structures Are Related to Past HIV Disease Severity in Youth With Perinatally Acquired HIV Infection.
Lewis-de Los Angeles CP; Alpert KI; Williams PL; Malee K; Huo Y; Csernansky JG; Yogev R; Van Dyke RB; Sowell ER; Wang L;
J Pediatric Infect Dis Soc; 2016 Dec; 5(suppl 1):S6-S14. PubMed ID: 27856671
[TBL] [Abstract][Full Text] [Related]
31. A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection.
Cardiello PG; Hassink E; Ananworanich J; Srasuebkul P; Samor T; Mahanontharit A; Ruxrungtham K; Hirschel B; Lange J; Phanuphak P; Cooper DA
Clin Infect Dis; 2005 Feb; 40(4):594-600. PubMed ID: 15712083
[TBL] [Abstract][Full Text] [Related]
32. CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial.
Danel C; Moh R; Minga A; Anzian A; Ba-Gomis O; Kanga C; Nzunetu G; Gabillard D; Rouet F; Sorho S; Chaix ML; Eholié S; Menan H; Sauvageot D; Bissagnene E; Salamon R; Anglaret X;
Lancet; 2006 Jun; 367(9527):1981-9. PubMed ID: 16782488
[TBL] [Abstract][Full Text] [Related]
33. Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the Italian Cohort of Antiretroviral-Naive Patients.
d'arminio Monforte A; Cozzi-Lepri A; Phillips A; De Luca A; Murri R; Mussini C; Grossi P; Galli A; Zauli T; Montroni M; Tundo P; Moroni M;
J Acquir Immune Defic Syndr; 2005 Apr; 38(4):407-16. PubMed ID: 15764957
[TBL] [Abstract][Full Text] [Related]
34. HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy.
Goujard C; Girault I; Rouzioux C; Lécuroux C; Deveau C; Chaix ML; Jacomet C; Talamali A; Delfraissy JF; Venet A; Meyer L; Sinet M;
Antivir Ther; 2012; 17(6):1001-9. PubMed ID: 22865544
[TBL] [Abstract][Full Text] [Related]
35. Impact of CD4 T cell count on the outcome of planned treatment interruptions in early-treated human immunodeficiency virus-infected children.
Fortuny C; Noguera-Julian A; Alsina L; Bellido R; Sánchez E; Muñoz-Almagro C; Ruiz L; Jiménez R
Pediatr Infect Dis J; 2011 May; 30(5):435-8. PubMed ID: 21030884
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of a pill-swallowing training intervention to improve antiretroviral medication adherence in pediatric patients with HIV/AIDS.
Garvie PA; Lensing S; Rai SN
Pediatrics; 2007 Apr; 119(4):e893-9. PubMed ID: 17353298
[TBL] [Abstract][Full Text] [Related]
37. Human immunodeficiency virus disease severity, psychiatric symptoms, and functional outcomes in perinatally infected youth.
Nachman S; Chernoff M; Williams P; Hodge J; Heston J; Gadow KD
Arch Pediatr Adolesc Med; 2012 Jun; 166(6):528-35. PubMed ID: 22312169
[TBL] [Abstract][Full Text] [Related]
38. Risk of first-line antiretroviral therapy failure in HIV-infected Thai children and adolescents.
Bunupuradah T; Sricharoenchai S; Hansudewechakul R; Klinbuayaem V; Teeraananchai S; Wittawatmongkol O; Akarathum N; Prasithsirikul W; Ananworanich J;
Pediatr Infect Dis J; 2015 Mar; 34(3):e58-62. PubMed ID: 25478649
[TBL] [Abstract][Full Text] [Related]
39. Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy.
Puthanakit T; Aurpibul L; Oberdorfer P; Akarathum N; Kanjananit S; Wannarit P; Sirisanthana T; Sirisanthana V
Clin Infect Dis; 2007 Feb; 44(4):599-604. PubMed ID: 17243067
[TBL] [Abstract][Full Text] [Related]
40. Discontinuation of antiretroviral therapy in patients with chronic HIV infection: clinical, virologic, and immunologic consequences.
Mata RC; Viciana P; de Alarcón A; López-Cortés LF; Gómez-Vera J; Trastoy M; Cisneros JM
AIDS Patient Care STDS; 2005 Sep; 19(9):550-62. PubMed ID: 16164382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
